About Fruitnik
Fruitnik is a publicly listed company based in Chennai (India) founded in 1958, and was acquired by Amrutanjan Health Care in March 2011. Fruit juices are manufactured and marketed across South India. Its Indian entity Amrutanjan Health Care Limited reported revenue of ₹520 Cr. Its focus areas include Food and Agriculture, Food & Beverage Products, Beverages and Juices and Dilutables. Its competitors include Raw Pressery, Shankar Group and Jagdale; 2 of its 3 listed competitors have raised funding.
Company details
Fruitnik was established in 1958 in Chennai, India, within the beverage sector. Operations focus on producing and distributing fruit-based juices, including varieties of mango, apple, lemon, and grape in multiple pack sizes. The brand gained prominence in South India before being acquired by Amrutanjan Healthcare in 2011 for Rs 26 crore. Products are handled through standard manufacturing and marketing channels.
- Headquarters Chennai, India
- Stage Acquired
- SectorsConsumer
- Website fruitnik.com
- Social LinkedIn X Facebook
- Acquired by Amrutanjan Health Care (Mar 2011)
- Legal Name Amrutanjan Health Care Limited
- Date of Incorporation 09 Sep, 1936
- Jurisdiction Chennai, Tamil Nadu, India
- Market Cap₹1,426 Cr
AMRUTANJAN · NSE
- Share Price₹496.65
+0.70% today
- Revenue₹187 Cr
FY 2015-16 · +12.1% YoY
- EBITDA₹30.78 Cr
Margin 16.5%
- Net Profit₹20.36 Cr
FY 2015-16 · +36.7% YoY
- P/E (TTM)46.2x
P/B 7.1x
- ROE20.2%
ROCE 31.4%
- Debt / Equity0.02
Interest cover 1.6x
- Investors
- Acquired byAmrutanjan Health Care
(Mar 2011)
Associated legal entities of Fruitnik
Fruitnik is associated with 2 registered companies on The Company Check; the primary company is Amrutanjan Health Care Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amrutanjan Health Care Limited Listed CIN L24231TN1936PLC000017 | Active | 09 Sep 1936 | Chennai, Tamil Nadu | ₹520 Cr | 671 | 8 | View details |
| Siva's Soft Drink Private Limited CIN U15542TN1998PTC040743 | Amalgamated | 30 Jun 1998 | Chennai, Tamil Nadu | 2 | View details |
Investors in Fruitnik
Fruitnik has secured backing from 1 investor. Prominent investors backing the company include Amrutanjan Health Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of ayurvedic healthcare products | 1893 | amrutanjan.com | Mumbai, India |
Investor details for Fruitnik
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Amrutanjan Health Care Limited (Fruitnik)
Amrutanjan Health Care Limited is the primary company behind Fruitnik. The boards of the 2 registered companies of Fruitnik currently have 7 directors; the longest-serving is Sambhuprasad Sivalenka, appointed in 2009. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sambhuprasad Sivalenka DIN 00015729 | Managing Director | 01 Apr 2009 | 17 yrs 6 mo | Amrutanjan Health Care Limited, Siva's Soft Drink Private Limited |
| Hanehallibhandimat Narayan Shetty DIN 00015465 | Director | 11 Mar 2011 | 15 yrs 7 mo | Siva's Soft Drink Private Limited |
| Swayambunathan Muralidharan DIN 09198315 | Director | 29 Jun 2021 | 5 yrs 4 mo | Amrutanjan Health Care Limited |
| Meenalochani Raghunathan DIN 07145001 | Director | 12 Aug 2022 | 4 yrs 2 mo | Amrutanjan Health Care Limited |
| Ramaa Prabhakar Arikirevula DIN 09465903 | Director | 30 Jun 2023 | 3 yrs 4 mo | Amrutanjan Health Care Limited |
| Nagaraj Viswanathan DIN 00190903 | Director | 13 Aug 2024 | 2 yrs 2 mo | Amrutanjan Health Care Limited |
| Ramaswami Krishnan DIN 08562199 | Director | 08 May 2026 | 5 mo | Amrutanjan Health Care Limited |
IPO & Listings of Fruitnik
Fruitnik is a publicly listed company on the NSE with ticker symbol AMRUTANJAN in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: AMRUTANJAN
- Listed entityAmrutanjan Health Care Limited
- Exchange sectorPharmaceuticals
Financials of Fruitnik
Exchange-reported figures of Amrutanjan Health Care Limited, the listed company behind Fruitnik (NSE: AMRUTANJAN).
Financial Highlights
FY 2015-16 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2015-16 | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 187 | 167 | 142 | 138 |
| Revenue growth | +12.1% | +17.5% | +3.0% | - |
| EBITDA | 30.78 | 23.59 | 21.80 | 17.41 |
| EBITDA margin | +16.5% | +14.2% | +15.4% | +12.7% |
| Profit before tax | 32.67 | 24.15 | 19.37 | 15.47 |
| Net profit | 20.36 | 14.89 | 13.02 | 9.92 |
| Net profit margin | +10.9% | +8.9% | +9.2% | +7.2% |
| EPS (₹) | 13.29 | 9.50 | 7.97 | 6.42 |
| Balance sheet | ||||
| Total assets | 112 | 98.45 | 98.25 | 98.30 |
| Net worth | 109 | 94.95 | 89.24 | 82.26 |
| Total debt | 2.50 | 2.50 | 8.00 | 15.12 |
| Cash & bank | 48.24 | 37.89 | 35.21 | 14.91 |
| Net working capital | 75.00 | 59.48 | 59.00 | 40.51 |
| Cash flow | ||||
| Cash from operations | 20.70 | 18.32 | 17.45 | 8.62 |
| Cash from investing | 4.16 | (4.89) | 16.49 | 13.49 |
| Cash from financing | (13.10) | (11.93) | (13.92) | (14.26) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 503 | 452 | 421 | 380 | 406 | 333 | 261 |
| Revenue growth | +11.2% | +7.3% | +11.0% | -6.5% | +21.9% | +27.3% | - |
| EBITDA | 67.00 | 58.31 | 51.92 | 44.54 | 79.57 | 74.84 | 30.83 |
| EBITDA margin | +13.3% | +12.9% | +12.3% | +11.7% | +19.6% | +22.5% | +11.8% |
| Profit before tax | 77.88 | 69.13 | 61.96 | 53.65 | 90.57 | 81.90 | 34.45 |
| Net profit | 64.18 | 50.83 | 44.88 | 39.82 | 67.17 | 61.12 | 25.08 |
| Net profit margin | +12.8% | +11.3% | +10.7% | +10.5% | +16.6% | +18.4% | +9.6% |
| EPS (₹) | 20.03 | 17.58 | 15.56 | 13.63 | 22.99 | 20.93 | 8.58 |
| Balance sheet | |||||||
| Total assets | 383 | 337 | 297 | 300 | 273 | 223 | 167 |
| Net worth | 370 | 327 | 288 | 291 | 265 | 216 | 159 |
| Total debt | 1.78 | 2.08 | 1.73 | 0.91 | 0.88 | 1.34 | 1.69 |
| Cash & bank | 33.32 | 83.16 | 26.61 | 70.32 | 87.75 | 139 | 36.33 |
| Net working capital | 163 | 206 | 226 | 192 | 190 | 166 | 87.33 |
| Cash flow | |||||||
| Cash from operations | 35.97 | 50.90 | 27.91 | 20.18 | 52.20 | 90.87 | 18.18 |
| Cash from investing | (21.23) | (30.97) | 19.17 | (2.48) | (36.21) | (87.76) | (13.85) |
| Cash from financing | (13.62) | (13.49) | (48.27) | (14.99) | (16.70) | (7.42) | (11.69) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 150 | 141 | 118 | 94.05 | 135 | 123 | 110 |
| Revenue growth (YoY) | +9.5% | +10.6% | +14.9% | +7.1% | +12.3% | - | - | - |
| Other income | 3.81 | 4.73 | 4.12 | 4.30 | 4.43 | 4.82 | 4.36 | 4.05 |
| Total expenses | 98.76 | 132 | 117 | 101 | 85.60 | 118 | 99.40 | 96.31 |
| EBITDA | 4.21 | 17.94 | 23.92 | 16.53 | 8.45 | 17.70 | 23.35 | 13.61 |
| EBITDA margin | +4.1% | +12.0% | +17.0% | +14.0% | +9.0% | +13.1% | +19.0% | +12.4% |
| Depreciation | 1.92 | 1.61 | 1.62 | 1.56 | 1.53 | 1.62 | 1.66 | 1.65 |
| Interest | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.06 |
| Profit before tax | 6.06 | 21.01 | 26.37 | 19.22 | 11.30 | 20.86 | 25.99 | 15.95 |
| Tax | 1.70 | 4.82 | 6.91 | 5.25 | 2.98 | 5.68 | 6.74 | 4.14 |
Financial Statements
| Particulars | FY 2015-16 | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|---|
| Revenue | 187 | 167 | 142 | 138 |
| Revenue growth | +12.1% | +17.5% | +3.0% | - |
| Other income | 5.68 | 4.48 | 2.94 | 4.27 |
| Total expenses | 156 | 143 | 120 | 120 |
| Employee cost | 28.55 | 25.87 | 22.82 | 21.03 |
| EBITDA | 30.78 | 23.59 | 21.80 | 17.41 |
| EBITDA margin | +16.5% | +14.2% | +15.4% | +12.7% |
| Depreciation | 3.35 | 3.21 | 3.60 | 3.73 |
| Interest | 0.44 | 0.71 | 1.77 | 2.48 |
| Profit before tax | 32.67 | 24.15 | 19.37 | 15.47 |
| Tax | 12.11 | 9.25 | 6.94 | 5.36 |
| Net profit | 20.36 | 14.89 | 13.02 | 9.92 |
| Net profit margin | +10.9% | +8.9% | +9.2% | +7.2% |
| EPS (₹) | 13.29 | 9.50 | 7.97 | 6.42 |
| Particulars | FY 2015-16 | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 2.92 | 2.92 | 2.92 | 2.92 |
| Reserves & surplus | 106 | 92.03 | 86.32 | 79.34 |
| Shareholders' funds (net worth) | 109 | 94.95 | 89.24 | 82.26 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 2.50 | 2.50 | 8.00 | 15.06 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.06 |
| Total debt | 2.50 | 2.50 | 8.00 | 15.12 |
| Total liabilities | 112 | 98.45 | 98.25 | 98.30 |
| Assets | ||||
| Gross block | 48.49 | 40.49 | 33.57 | 46.74 |
| Net block | 28.82 | 24.09 | 26.76 | 29.98 |
| Capital work in progress | 0.82 | 3.77 | 0.97 | 0.62 |
| Investments | 8.99 | 9.10 | 9.13 | 24.96 |
| Inventories | 8.97 | 8.61 | 8.72 | 10.24 |
| Sundry debtors | 27.59 | 27.64 | 24.97 | 28.25 |
| Cash & bank balances | 48.24 | 37.89 | 35.21 | 14.91 |
| Loans & advances | 15.69 | 8.70 | 9.34 | 9.98 |
| Total current assets | 100 | 82.84 | 78.24 | 63.38 |
| Total current liabilities | 25.49 | 23.36 | 19.24 | 22.87 |
| Net working capital | 75.00 | 59.48 | 59.00 | 40.51 |
| Total assets | 112 | 98.45 | 98.25 | 98.30 |
| Particulars | FY 2015-16 | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|---|
| Opening cash | 30.67 | 29.17 | 9.15 | 7.06 |
| Net cash from operating activities | 20.70 | 18.32 | 17.45 | 8.62 |
| Net cash from investing activities | 4.16 | (4.89) | 16.49 | 13.49 |
| Net cash from financing activities | (13.10) | (11.93) | (13.92) | (14.26) |
| Net change in cash | 11.76 | 1.49 | 20.02 | 7.85 |
| Closing cash | 48.24 | 37.89 | 35.21 | 14.91 |
| Particulars | FY 2015-16 | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +12.1% | +17.5% | +3.0% | - |
| EBITDA growth | +30.5% | +8.2% | +25.2% | - |
| PBT growth | +35.3% | +24.7% | +25.2% | +9997.0% |
| Net income growth | +36.7% | +14.4% | +31.3% | - |
| Revenue CAGR (3Y) | +10.7% | - | - | - |
| EBITDA CAGR (3Y) | +20.9% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +11.0% | +9.0% | +8.8% | +7.3% |
| Return on capital employed | +31.4% | +25.3% | +21.5% | +18.1% |
| Return on net worth | +20.2% | +16.2% | +14.5% | +12.7% |
| Debt / equity | 0.02 | 0.06 | 0.13 | 0.23 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.04 |
| Interest cover | 1.60 | 3.48 | 9.73 | 18.13 |
| Efficiency & per share | ||||
| Fixed asset turnover | 4.40 | 4.72 | 3.71 | 3.14 |
| Inventory turnover | 22.27 | 20.18 | 15.69 | 12.40 |
| Debtors turnover | 7.09 | 6.65 | 5.59 | 6.32 |
| EPS (₹) | 13.29 | 9.50 | 7.97 | 6.42 |
| Dividend per share (₹) | 3.85 | 3.50 | 3.20 | 3.00 |
| Book value per share (₹) | 74.40 | 64.97 | 61.06 | 56.29 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 150 | 141 | 118 | 94.05 | 135 | 123 | 110 |
| Revenue growth (YoY) | +9.5% | +10.6% | +14.9% | +7.1% | +12.3% | - | - | - |
| Other income | 3.81 | 4.73 | 4.12 | 4.30 | 4.43 | 4.82 | 4.36 | 4.05 |
| Total expenses | 98.76 | 132 | 117 | 101 | 85.60 | 118 | 99.40 | 96.31 |
| EBITDA | 4.21 | 17.94 | 23.92 | 16.53 | 8.45 | 17.70 | 23.35 | 13.61 |
| EBITDA margin | +4.1% | +12.0% | +17.0% | +14.0% | +9.0% | +13.1% | +19.0% | +12.4% |
| Depreciation | 1.92 | 1.61 | 1.62 | 1.56 | 1.53 | 1.62 | 1.66 | 1.65 |
| Interest | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.06 |
| Profit before tax | 6.06 | 21.01 | 26.37 | 19.22 | 11.30 | 20.86 | 25.99 | 15.95 |
| Tax | 1.70 | 4.82 | 6.91 | 5.25 | 2.98 | 5.68 | 6.74 | 4.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 503 | 452 | 421 | 380 | 406 | 333 | 261 |
| Revenue growth | +11.2% | +7.3% | +11.0% | -6.5% | +21.9% | +27.3% | - |
| Other income | 17.57 | 17.68 | 16.35 | 14.54 | 15.38 | 11.32 | 8.32 |
| Total expenses | 436 | 394 | 369 | 335 | 326 | 258 | 231 |
| Employee cost | 63.76 | 59.10 | 47.69 | 48.81 | 48.23 | 41.70 | 39.36 |
| EBITDA | 67.00 | 58.31 | 51.92 | 44.54 | 79.57 | 74.84 | 30.83 |
| EBITDA margin | +13.3% | +12.9% | +12.3% | +11.7% | +19.6% | +22.5% | +11.8% |
| Depreciation | 6.32 | 6.53 | 6.06 | 5.21 | 3.80 | 3.67 | 4.36 |
| Interest | 0.37 | 0.33 | 0.25 | 0.22 | 0.58 | 0.59 | 0.34 |
| Profit before tax | 77.88 | 69.13 | 61.96 | 53.65 | 90.57 | 81.90 | 34.45 |
| Tax | 19.97 | 18.30 | 16.97 | 13.81 | 23.39 | 20.71 | 9.37 |
| Net profit | 64.18 | 50.83 | 44.88 | 39.82 | 67.17 | 61.12 | 25.08 |
| Net profit margin | +12.8% | +11.3% | +10.7% | +10.5% | +16.6% | +18.4% | +9.6% |
| EPS (₹) | 20.03 | 17.58 | 15.56 | 13.63 | 22.99 | 20.93 | 8.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 2.89 | 2.89 | 2.89 | 2.92 | 2.92 | 2.92 | 2.92 |
| Reserves & surplus | 367 | 324 | 286 | 288 | 262 | 213 | 156 |
| Shareholders' funds (net worth) | 370 | 327 | 288 | 291 | 265 | 216 | 159 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 1.78 | 2.08 | 1.73 | 0.91 | 0.88 | 1.34 | 1.69 |
| Total debt | 1.78 | 2.08 | 1.73 | 0.91 | 0.88 | 1.34 | 1.69 |
| Total liabilities | 383 | 337 | 297 | 300 | 273 | 223 | 167 |
| Assets | |||||||
| Gross block | 88.73 | 81.24 | 75.20 | 73.10 | 47.84 | 39.30 | 39.04 |
| Net block | 51.25 | 49.41 | 49.53 | 48.92 | 28.46 | 23.26 | 26.11 |
| Capital work in progress | 106 | 16.25 | 2.39 | 1.11 | 17.33 | 1.57 | 0.00 |
| Investments | 3.12 | 0.05 | 0.04 | 5.17 | 12.88 | 17.84 | 18.21 |
| Inventories | 37.35 | 27.26 | 28.90 | 28.83 | 26.00 | 17.46 | 23.72 |
| Sundry debtors | 60.64 | 55.82 | 47.89 | 33.02 | 38.26 | 17.66 | 26.46 |
| Cash & bank balances | 33.32 | 83.16 | 26.61 | 70.32 | 87.75 | 139 | 36.33 |
| Loans & advances | 157 | 124 | 192 | 123 | 115 | 42.63 | 39.31 |
| Total current assets | 289 | 291 | 296 | 255 | 267 | 217 | 126 |
| Total current liabilities | 126 | 84.18 | 69.59 | 62.50 | 76.90 | 51.47 | 38.49 |
| Net working capital | 163 | 206 | 226 | 192 | 190 | 166 | 87.33 |
| Total assets | 383 | 337 | 297 | 300 | 273 | 223 | 167 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 10.16 | 3.71 | 4.90 | 2.19 | 2.91 | 7.22 | 14.59 |
| Net cash from operating activities | 35.97 | 50.90 | 27.91 | 20.18 | 52.20 | 90.87 | 18.18 |
| Net cash from investing activities | (21.23) | (30.97) | 19.17 | (2.48) | (36.21) | (87.76) | (13.85) |
| Net cash from financing activities | (13.62) | (13.49) | (48.27) | (14.99) | (16.70) | (7.42) | (11.69) |
| Net change in cash | 1.12 | 6.44 | (1.19) | 2.72 | (0.72) | (4.32) | (7.36) |
| Closing cash | 33.32 | 83.16 | 26.61 | 70.32 | 87.75 | 139 | 36.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +11.2% | +7.3% | +11.0% | -6.5% | +21.9% | +27.3% | - |
| EBITDA growth | +14.9% | +12.3% | +16.6% | -44.0% | +6.3% | +142.8% | - |
| PBT growth | +12.7% | +11.6% | +15.5% | -40.8% | +10.6% | +137.7% | -0.7% |
| Net income growth | +26.3% | +13.3% | +12.7% | -40.7% | +9.9% | +143.7% | - |
| Revenue CAGR (3Y) | +9.8% | +3.6% | +8.2% | +13.2% | +17.0% | +14.8% | +8.1% |
| EBITDA CAGR (3Y) | +14.6% | -9.8% | -11.5% | +13.1% | +37.0% | +38.5% | +2.2% |
| Profitability & leverage | |||||||
| Net income margin | +11.5% | +11.3% | +10.7% | +10.5% | +16.6% | +18.4% | +9.6% |
| Return on capital employed | +24.2% | +21.9% | +20.8% | +18.8% | +36.8% | +42.3% | +21.9% |
| Return on net worth | +18.4% | +16.5% | +15.5% | +14.3% | +28.0% | +32.6% | +16.4% |
| Debt / equity | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Long-term debt / equity | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.61 | 0.64 | 0.55 | 0.56 | 0.77 | 0.83 | 1.28 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 5.91 | 5.78 | 5.68 | 6.28 | 9.31 | 8.50 | 7.09 |
| Inventory turnover | 15.56 | 16.09 | 14.59 | 13.85 | 18.68 | 16.17 | 13.65 |
| Debtors turnover | 8.63 | 8.71 | 10.41 | 10.65 | 14.52 | 15.09 | 8.81 |
| EPS (₹) | 20.03 | 17.58 | 15.56 | 13.63 | 22.99 | 20.93 | 8.58 |
| Dividend per share (₹) | 4.90 | 4.60 | 4.60 | 4.60 | 4.60 | 4.20 | 2.10 |
| Book value per share (₹) | 128.06 | 112.97 | 99.78 | 99.47 | 90.70 | 73.75 | 54.54 |
Timeline of Fruitnik
2 dated milestones of Fruitnik across 53 years, from founding to its latest funding, stage changes and deals.
- Founded Fruitnik is founded.
- Exit Acquired by Amrutanjan Health Care.
Competitors of Fruitnik
Fruitnik has 3 listed competitors in our database, 2 of them funded. They include Raw Pressery, Shankar Group and Jagdale.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rawpressery.com | 2013 | Mumbai, India | $32.81M | 381 | Brand of cold-pressed juices | |
| sgcorporates.com | 1987 | Puttur, India | $263,438 | 399 | Packaged foods, beverages, and auto parts are produced in India. | |
| jagdale.com | 1991 | Bengaluru, India | 120 | Diversified company with divisions in pharma, foods, exports, and services. |
Detailed competitors of Fruitnik
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Food & Beverage Products & Processing
3 companies that operate in the same segment as Fruitnik (Food & Beverage Products & Processing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Platform offering a subscription-based delivery service for fresh milk and groceries | 2015 | Gurugram, Haryana, India | USD 228.42 M | USD 99.78 M | 3,464 | |
Subscription-based coffee products are offered by an internet-first brand. | 2013 | Gurugram, Haryana, India | USD 112.84 M | USD 25.83 M | 2,059 | |
Meat and seafood products are delivered via an online platform. | 2015 | Bengaluru, Karnataka, India | USD 564.84 M | USD 97.26 M | 2,828 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fruitnik
Complete news archive for Fruitnik
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fruitnik
Fruitnik was founded in 1958.
Fruitnik is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind Fruitnik, Amrutanjan Health Care Limited, reported revenue of ₹520 Cr for FY 2026, up 11% year on year.
Fruitnik was established in 1958 in Chennai, India, within the beverage sector. Operations focus on producing and distributing fruit-based juices, including varieties of mango, apple, lemon, and grape in multiple pack sizes. The brand gained prominence in South India before being acquired by Amrutanjan Healthcare in 2011 for Rs 26 crore. Products are handled through standard manufacturing and marketing channels.
Fruitnik's top competitors include Shankar Group, Raw Pressery and Jagdale.
Yes, Fruitnik is publicly traded on NSE under the ticker symbol AMRUTANJAN.
Fruitnik has 1 investor. Key investors include Amrutanjan Health Care.
Fruitnik is associated with 2 legal entities: Amrutanjan Health Care Limited, Siva's Soft Drink Private Limited.
Yes. Fruitnik was acquired by Amrutanjan Health Care in March 2011.
The legal entities of Fruitnik currently have 9 directors, including Meenalochani Raghunathan, Sambhuprasad Sivalenka, Swayambunathan Muralidharan and others.